A Search Service for Abbreviation / Long Form

■ 検索結果 - 略語 : PACAP

検索条件:
検索語 : PACAP
検索方法 : 完全一致
主な研究分野:

結果:  
略語: PACAP
出現頻度: 2997
対応する展開形の数: 8

表示設定:
[1ページの件数]
ページ移動
/ ページ
展開形 No. 展開形 主な研究分野 共起略語 PubMed/MEDLINE情報 (発表年, 題目)
pituitary adenylate cyclase-activating polypeptide
(視床下部ホルモン) 脳下垂体アデニル酸シクラーゼ活性化ポリペプチド, 下垂体アデニル酸シクラーゼ活性化ポリペプチド
(2983 回)
Neurology
神経学, 神経内科学
(724 回)
VIP (781 回)
CGRP (119 回)
PKA (98 回)
1990 Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
activating polypeptide
(3 回)
Genetics
遺伝学
(1 回)
BDNF (1 回)
ERK (1 回)
GAP-43 (1 回)
1995 The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain.
cyclase-activating polypeptide
(3 回)
Neurology
神経学, 神経内科学
(2 回)
ACL (1 回)
AVP (1 回)
CRH (1 回)
1997 Day-night variation of pituitary adenylate cyclase-activating polypeptide (PACAP) level in the rat suprachiasmatic nucleus.
proapoptotic caspase adaptor protein
(3 回)
Lung Neoplasms

(1 回)
Casp2 (1 回)
ELISA (1 回)
2001 Characterization of a novel proapoptotic caspase-2- and caspase-9-binding protein.
Pancreatic Cancer Project
(2 回)
Health Services
公共医療
(1 回)
BSC (1 回)
FOP (1 回)
OS (1 回)
2020 Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial.
possible control mechanism for an increased expression of one peptide
(1 回)
Biochemistry
生化学, 生物化学
(1 回)
GHRH (1 回)
1993 Two salmon neuropeptides encoded by one brain cDNA are structurally related to members of the glucagon superfamily.
possible role of adenylate cyclase-activating polypeptide
(1 回)
Biology
生物学
(1 回)
AC (1 回)
AR (1 回)
COX (1 回)
2002 Pituitary adenylate cyclase-activating polypeptide induces testicular testosterone synthesis through PGE(2) mediation in crested newt, Triturus carnifex.
prophylactic anticoagulation+antiplatelet
(1 回)
aHR (1 回)
ICU (1 回)
PAC (1 回)
2021 Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.